v3 Template
M

Mithradote Bio

Biotechnology ~90 employees
Founded
--
Employees (Est.)
~90
6 leaders known
Total Funding
$1.0M
Funding Rounds
1
Last Funding
2024-10-02

About Mithradote Bio

Mithradote Bio is a biotechnology company focused on developing a novel medication to help prevent drug-facilitated sexual assault by creating the first self-administered antidote against drink spiking drugs.

Products & Services

M-101:A novel sublingual pan-antidote against benzodiazepines (e.g., Rohypnol/'roofies,' Valium, Versed), 'Z drugs,' and other GABA agonists. It offers rapid absorption for fast action and is convenient to carry.

Specialties

Development of antidotes for drink spiking drugs Sublingual medication technology Prevention of drug-facilitated sexual assault

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 1000000
MR: -
FA: 1 million
FAN: 1000000 		D: 2024-10-02
FD: 2024-10-02 		2 investors
Seed Latest
2024-10-02
$1.0M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jerold Chun, M.D., PhD.

Professor and Senior Vice President of Neuroscience Drug Discovery

K

Katja Buhrer

Senior Vice President, Head of Corporate Affairs and Strategy

A

Alex Lee

T

Tien Lee, M.D.

M.D.

S

Sophia Lee

J

Jane Lee, M.D.

Founder & CEO

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

Mithradote Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~90 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro